Other
Bleeding
3
Pipeline Programs↗
15
Active Trials↗
10
Companies Involved↗
Bleeding is an early-stage landscape with 3 programs across 10 companies. The most active players are Bayer, Octapharma, Amring. 1 program is in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Phase 1
No programs
Phase 2
No programs
Phase 31
Approved
No programs
Analysis
Trial Status
83
clinical trials
Completed45 · 54%
Unknown status14 · 17%
Recruiting11 · 13%
Terminated8 · 10%
Not yet recruiting3 · 4%
Active, not recruiting1 · 1%
Other1 · 1%
Clinical Trials
Trial Activity
83 trials
Liberal or Adhere to Recommendations for PCC Management in Major Bleeding Following Trauma
Recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·N/A·NCT06627218·650 enrolled
Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users
Recruiting·—·Phase 2·NCT07083635·40 enrolled
Life-2023-02 Esophagogastric Variceal Bleeding
Recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·N/A·NCT06011980·33 enrolled
Page 1 of 6
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)